Effects of Oxygen Supply After Lung Isolation in Thoracic Surgery

Sponsor
Medical University Innsbruck (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05946707
Collaborator
(none)
55
1
2
21.4
2.6

Study Details

Study Description

Brief Summary

The goal of this randomized clinical trial is to compare a liberal versus restrictive oxygen supply (fraction of inspired oxygen, FiO2) strategy in patients scheduled for thoracic surgery requiring one-lung ventilation during lung isolation. The primary and secondary outcome parameters are:

  • oxygenation of the blood after 30 minutes of one-lung ventilation, assessed by PaO2/FiO2 ratio

  • time to lung collapse after start of one-lung ventilation

Participants in the control goup will receive an oxygen content of 100% before lung isolation, which will be subsequently decreased to achieve normoxia or mild hyperoxia (PaO2 of 75-120 mmHg).

The intervention group will receive the previous, during two-lung ventilation set, oxygen content and after lung isolation oxygen supply will be increased to secure adequate oxygenation of the blood (PaO2 75-120 mmHg) during one-lung ventilation.

The investigators hypothesize, that a higher fraction of inspired oxygen may impede hypoxic pulmonary vasoconstriction of the collapsed lung and thus decrease overall oxygenation performance during one-lung ventilation. Secondary endpoint will be the time to lung collapse, as a lower fraction of inspired oxygen and thus a higher nitrogen content may impede lung collapse.

Condition or Disease Intervention/Treatment Phase
  • Drug: restrictive oxygen supply
  • Drug: liberal oxygen supply
N/A

Detailed Description

After anesthesia induction and securing the airway with a double lumen tracheal tube, the patient will be ventilated with pressure-controlled ventilation (PCV) and the following settings during two-lung ventilation (TLV): positive end-expiratory pressure of 5 cmH2O, peak pressure set to achieve a tidal volume of 6-8 ml/kg, respiratory rate set to achieve normocapnia, I:E ratio set to 1:1.5, FiO2 adjusted to achieve normoxia. After changing to lateral position, the patient will be randomized to one of the following group:

  • Decremental FiO2 titration: FiO2 will be set to 1.0 five minutes before lung isolation and reduced consecutively during one-lung ventilation (OLV) according to paO2 measurement obtained from arterial blood gas samples to achieve normoxia (paO2 of 75-120 mmHg).

  • Incremental FiO2 titration: FiO2 will be maintained to secure normoxia during the entire surgery. This means, that the previous FiO2 setting during two-lung ventilation will be continued and after OLV initiation the FiO2 has to be adjusted, to secure normoxia assessed by continuous SpO2 measurement (SpO2 of 92-96 %) and paO2 measurement obtained from arterial blood gas samples (paO2 of 75-120 mmHg).

During OLV the applied tidal volume will be reduced to 4-6 ml/kg by an appropriate adjustment of peak pressure, otherwise the ventilator settings will not be changed. After 30 minutes of OLV the intervention period ends and because in both groups oxygenation will be adjusted to achieve a PaO2 of 75-120 mmHg during OLV, the routine anesthetic regime of both groups will not differ in the further course of thoracic surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
55 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
non-blinded, randomized, controlled trialnon-blinded, randomized, controlled trial
Masking:
Single (Participant)
Masking Description:
Study participants will be randomized after induction of general anesthesia and thus are not aware of the treatment arm, which solely differs at the time of lung isolation.
Primary Purpose:
Treatment
Official Title:
Effects of Oxygen Supply on Hypoxic Pulmonary Vasoconstriction and Lung Collapse After Lung Isolation in Thoracic Surgery - a Prospective, Randomized Clinical Trial
Anticipated Study Start Date :
Jul 18, 2023
Anticipated Primary Completion Date :
Apr 30, 2025
Anticipated Study Completion Date :
Apr 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: high oxygen: decremental FiO2 titration

Five minutes before lung isolation fraction of inspired oxygen will be increased to 1.0, representing the standard procedure for one-lung ventilation. 10, 20 and 30 minutes after OLV initiation paO2 obtained from arterial blood gas analysis will be measured and FiO2 titrated to achieve a paO2 of 75-120 mmHg.

Drug: liberal oxygen supply
Oxygen supply will be maximized to 100% at the beginning of OLV

Experimental: low oxygen: incremental FiO2 titration

Before lung isolation fraction of inspired oxygen will be maintained as previously set to guarantee normoxia (SpO2 >92%). During OLV SpO2 will be continuously monitored and FiO2 adjusted to keep SpO2 >92%. Additionally after 10, 20 and 30 minutes after OLV initiation paO2 obtained from arterial blood gas analysis will be measured and FiO2 more precisely titrated to achieve a paO2 of 75-120 mmHg.

Drug: restrictive oxygen supply
Oxygen supply will be limited to guarantee normoxia at the beginning of OLV.

Outcome Measures

Primary Outcome Measures

  1. oxygenation of the blood [Primary outcome timepoint is defined at 30 minutes after start of OLV]

    Oxygenation of the blood will be assessed by the paO2/FiO2 ratio and compared between groups.

Secondary Outcome Measures

  1. lung collapse [Lung collapse will be assessed and recorded as no collapse, partial collapse or complete collapse at 10, 20, 30 and 60 minutes after start of one-lung ventilation.]

    Time to complete lung collapse will be recorded and compared between groups.

  2. postoperative pulmonary complication [Follow-up will be completed after end of hospital stay or 30-days of hospital stay.]

    Occurence of postoperative pulmonary complications will be assessed postoperatively

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male and female subjects ≥ 18 years

  • Elective thoracic surgery requiring OLV

  • American Society of Anesthesiologists physical status classification I-III

  • Written informed consent

Exclusion Criteria:
  • Emergency surgery

  • Female subjects known to be pregnant

  • Known participation in another interventional clinical trial

  • Empyema evacuation or signs of pulmonary infection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University Innsbruck Innsbruck Tyrol Austria 6020

Sponsors and Collaborators

  • Medical University Innsbruck

Investigators

  • Principal Investigator: Patrick Spraider, MD, Medical University of Innsbruck, Department of Anesthesiology and Intensive Care Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University Innsbruck
ClinicalTrials.gov Identifier:
NCT05946707
Other Study ID Numbers:
  • 1051/2023
First Posted:
Jul 14, 2023
Last Update Posted:
Jul 14, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Medical University Innsbruck
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 14, 2023